Should Britain give away its vaccines?
Jan 29, 2021•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Novavax's vaccine has shown 89 per cent efficacy in UK trials. The government has bought 60 million doses of the jab, and it's expected that production will begin in Teesside later this year. But, as the EU's rollout languishes and their row with AstraZeneca escalates, should Britain consider giving away its vaccines? Katy Balls speaks to James Forsyth and Fraser Nelson.
Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.
For more Spectator podcasts, go to spectator.co.uk/podcasts.
Contact us: podcast@spectator.co.uk
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android